Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TA-650 (infliximab) in patients with ankylosing spondylitis
jRCT2080220341Phase 3
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jan 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of infliximab in ankylosing spondylitis (AS), sponsored by Mitsubishi Tanabe Pharma Corporation.
02
Drugs
infliximab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on jRCT2080220341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220341.